If 1801 fails then this becomes a shell and should trade around cash backing, dependent upon them getting rid of all the ridiculous salaries they're paying. Hopefully they'll still have a good pile of cash left to pick up a new project and fund the initial stages.
I do have a bit of hope for 1801 though, need to spend some more time closer to the trial results to really look through the details but the recent announcement looked good on first read - just worried about the fine print i might have missed
Botanix Pharmaceuticals Downgraded to Hold from Buy by Bell Potter, page-10
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
-0.015(3.75%) |
Mkt cap ! $693.8M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 38.3¢ | $1.806M | 4.591M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 293244 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 265584 | 15 |
View Market Depth
| Last trade - 14.31pm 03/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |